Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials

    Nephrology Dialysis Transplantation Date published:

  • Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials

    Nephrology Dialysis Transplantation Date published:

  • Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction

    Diabetes Care Date published:

  • Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials

    BMJ Date published:

  • Global kidney disease

    The Lancet Date published:

  • Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis

    Nephrology Dialysis Transplantation Date published:

  • HMG CoA reductase inhibitors (statins) for dialysis patients

    Cochrane Database of Systematic Reviews Date published:

  • Tripterygium Preparations for the Treatment of CKD: A Systematic Review and Meta-analysis

    American Journal of Kidney Diseases Date published:

  • Industry-Sponsored Clinical Trials in Emerging Markets

    JAMA Date published:

  • The Authors Reply

    Kidney International Date published:

  • Interventions for erythropoietin-resistant anaemia in dialysis patients

    Cochrane Database of Systematic Reviews Date published:

  • Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)-A randomized placebo-controlled trial

    American Heart Journal Date published:

  • High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus

    European Heart Journal Date published:

  • Antioxidants for chronic kidney disease

    Nephrology Date published:

  • Antioxidants for chronic kidney disease

    Nephrology Date published:

  • Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Sulfonylurea (SU) Monotherapy: A CANVAS Substudy

    Date published: